Navigation Links
Doubling a gene in corn results in giant biomass
Date:3/18/2009

University of Illinois plant geneticist Stephen Moose has developed a corn plant with enormous potential for biomass, literally. It yields corn that would make good silage, Moose said, due to a greater number of leaves and larger stalk, which could also make it a good energy crop.

The gene known as Glossy 15 was originally described for its role in giving corn seedlings a waxy coating that acts like a sun screen for the young plant. Without Glossy 15, seedling leaves instead appear shiny and glossy in sunlight. Further studies have shown that the main function of Glossy15 is to slow down shoot maturation. Moose wondered what would happen if they turned up the action of this gene. "What happens is that you get bigger plants, possibly because they're more sensitive to the longer days of summer. We put a corn gene back in the corn and increased its activity. So, it makes the plant slow down and gets much bigger at the end of the season."

The ears of corn have fewer seeds compared to the normal corn plant and could be a good feed for livestock. "Although there is less grain there is more sugar in the stalks, so we know the animal can eat it and they'll probably like it." This type of corn plant may fit the grass-fed beef standard, Moose said.

"The first time I did this, I thought, well, maybe the seeds just didn't get pollinated very well, so I hand pollinated these ears to make sure. I found that just like the shoot, seed development is also slower and they just don't make it all the way to the end with a plump kernel," Moose said.

He explained that the energy to make the seed goes instead into the stalk and leaves. "We had been working with this gene for awhile. We thought there would be more wax on the leaves and there was. But we also got this other benefit, that it's a lot bigger."

Moose tested his hypothesis with other corn lines and the effect was the same. "We essentially can make any corn variety bigger with
'/>"/>

Contact: Debra Levey Larson
dlarson@illinois.edu
217-244-2880
University of Illinois at Urbana-Champaign
Source:Eurekalert

Page: 1 2

Related biology news :

1. Doubling a gene in corn results in giant biomass
2. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
3. Results of national nursery survey unveiled
4. Results of the third school nutrition dietary assessment study published
5. Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008
6. UH Manoa researchers release results of statewide survey of snail, slug invasions in Hawaii
7. bioMETRX, Inc. Highlights 3rd Quarter 2008 Financial Results
8. Orchid Cellmark Reports Third Quarter 2008 Financial Results
9. Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea
10. First results from hospital trials testing
11. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2